Publication:
Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

3

Suggested Citation

Wirongrong Chierakul, Siriluck Anunnatsiri, Wipada Chaowagul, Sharon J. Peacock, Ploenchan Chetchotisakd, Nicholas P. Day Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]. Clinical Infectious Diseases. Vol.45, No.4 (2007), 521-523. doi:10.1086/520011 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/24784

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Availability

Collections